Wedbush maintains a 'Neutral' on United Therapeutics (Nasdaq: UTHR), price target increased from $58 to $62.

Wedbush analyst says, "Due ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE